Requirement of MAP kinase for differentiation of fibroblasts to adipocytes, for insulin activation of p90 S6 kinase and for insulin or serum stimulation of DNA synthesis - PubMed (original) (raw)
Requirement of MAP kinase for differentiation of fibroblasts to adipocytes, for insulin activation of p90 S6 kinase and for insulin or serum stimulation of DNA synthesis
E M Sale et al. EMBO J. 1995.
Abstract
A phosphorothioate-oligonucleotide-based antisense strategy for depleting MAP kinase was developed. The 17mer antisense probe, EAS 1, caused a potent and concentration-dependent decrease in the steady state expression of p42 and p44 MAP kinase in 3T3 L1 fibroblasts and adipocytes with submicromolar concentrations effective. Antisense EAS 1 elicited a dose-dependent inhibition of insulin- and serum-stimulated DNA synthesis. Elimination of p42 MAP kinase by > 95% and p44 MAP kinase to levels undetected blocked the ability of serum in 3T3 L1 fibroblasts and insulin in 3T3 L1 adipocytes to stimulate DNA synthesis by 87-95%. The differentiation of 3T3 L1 fibroblasts into adipocytes was prevented by 1 microM antisense EAS 1. The corresponding sense, scrambled or sense plus antisense EAS 1 phosphorothioate oligonucleotides did not deplete the p42 or p44 MAP kinase from either cell type, did not inhibit stimulation of DNA synthesis and did not interfere with differentiation. Two kinases on different MAP kinase activation pathways were not depleted by antisense EAS 1 whereas the ability of insulin to activate p90 S6 kinase was > 90% eliminated in 3T3 L1 adipocytes by 4.5 microM antisense EAS 1. In conclusion these results show that MAP kinase is required for insulin and serum stimulation of DNA synthesis, for insulin stimulation of p90 S6 kinase activity and for differentiation of 3T3 L1 cells. Moreover, the development of the antisense probe EAS 1 against a target sequence of p42 MAP kinase that is conserved in p44 MAP kinase and across a range of species provides a molecular tool of general applicability for further dissecting the precise targets and roles of MAP kinase.
Similar articles
- The insulin/Ras pathway of adipocytic differentiation of 3T3 L1 cells: dissociation between Raf-1 kinase and the MAPK/RSK cascade.
Porras A, Santos E. Porras A, et al. Int J Obes Relat Metab Disord. 1996 Mar;20 Suppl 3:S43-51. Int J Obes Relat Metab Disord. 1996. PMID: 8680477 Review.
Cited by
- Germinated Rice Seeds Improved Resveratrol Production to Suppress Adipogenic and Inflammatory Molecules in 3T3-L1 Adipocytes.
Monmai C, Kim JS, Baek SH. Monmai C, et al. Molecules. 2023 Jul 29;28(15):5750. doi: 10.3390/molecules28155750. Molecules. 2023. PMID: 37570719 Free PMC article. - Anti-Obesity Effect of Polygalin C Isolated from Polygala japonica Houtt. via Suppression of the Adipogenic and Lipogenic Factors in 3T3-L1 Adipocytes.
Jee W, Lee SH, Ko HM, Jung JH, Chung WS, Jang HJ. Jee W, et al. Int J Mol Sci. 2021 Sep 27;22(19):10405. doi: 10.3390/ijms221910405. Int J Mol Sci. 2021. PMID: 34638751 Free PMC article. - Autologous decellularized extracellular matrix promotes adipogenic differentiation of adipose derived stem cells in low serum culture system by regulating the ERK1/2-PPARγ pathway.
Qian Y, Chen H, Pan T, Li T, Zhang Z, Lv X, Wang J, Ji Z, He Y, Li L, Lin M. Qian Y, et al. Adipocyte. 2021 Dec;10(1):174-188. doi: 10.1080/21623945.2021.1906509. Adipocyte. 2021. PMID: 33825675 Free PMC article. - Adipogenic function of tetranectin mediated by enhancing mitotic clonal expansion via ERK signaling.
Go S, Park J, Rahman S, Jin J, Choi I, Kim J. Go S, et al. BMB Rep. 2021 Jul;54(7):374-379. doi: 10.5483/BMBRep.2021.54.7.024. BMB Rep. 2021. PMID: 33691910 Free PMC article. - The Role of Pref-1 during Adipogenic Differentiation: An Overview of Suggested Mechanisms.
da Silva C, Durandt C, Kallmeyer K, Ambele MA, Pepper MS. da Silva C, et al. Int J Mol Sci. 2020 Jun 9;21(11):4104. doi: 10.3390/ijms21114104. Int J Mol Sci. 2020. PMID: 32526833 Free PMC article. Review.
References
- J Biol Chem. 1978 Oct 25;253(20):7570-8 - PubMed
- Trends Biochem Sci. 1994 Jun;19(6):236-40 - PubMed
- Biochem J. 1988 Mar 1;250(2):509-19 - PubMed
- Nature. 1988 Aug 25;334(6184):715-8 - PubMed
- Biochem J. 1988 Dec 15;256(3):903-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical